🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary Objective: * To describe the safety profile of the SP MenB vaccine...
Status
Terminated
Location
Lakeview Clinical Research Site Number : 8400029
Start Date
2021-03-29
Trial ID
NCT04825223
Treatments Being Tested
Primary Objective: To demonstrate the vaccine seroresponse sufficiency of ...
Status
Completed
Location
Investigational Site Number 8400012
Start Date
2019-09-03
Trial ID
NCT04084769
Primary Objective: To demonstrate sufficiency of the vaccine seroresponse ...
Status
Completed
Location
Investigational Site Number 8400026
Start Date
2019-10-04
Trial ID
NCT04142242
Primary Objective: To demonstrate: * the non-inferiority of the seroprote...
Status
Completed
Location
Investigational Site Number 2080001
Start Date
2019-09-12
Trial ID
NCT03890367
The purpose of this study is to describe the safety and immunogenicity of M...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-08-20
Trial ID
NCT07710872
The purpose of the study was to evaluate the immunogenicity and describe th...
Status
Completed
Location
Investigational Site
Start Date
2017-02-17
Trial ID
NCT03077438
This is a Phase 3, modified double-blind, randomized, parallel-group, activ...
Status
Active Not Recruiting
Location
Investigational Site Number : 1561000
Start Date
2025-09-26
Trial ID
NCT07135986
Treatments Being Tested
The MEQ00074 study was a Phase III, open-label, single-center study aimed a...
Status
Completed
Location
Investigational Site Number : 7040001
Start Date
2024-01-18
Trial ID
NCT06228586
Treatments Being Tested
The purpose of this study was to compare the immunogenicity and describe th...
Status
Completed
Location
Birmingham Pediatric Associates Site Number : 8400026
Start Date
2018-04-25
Trial ID
NCT03537508
This was an open-label, multi-center study to describe the immune persisten...
Status
Completed
Location
Sanofi Pasteur Investigational Site 2460005
Start Date
2018-02-27
Trial ID
NCT03476135
Treatments Being Tested